高效选择性H3K27组蛋白脱甲基酶抑制剂;Potent and selective H3K27 histone demethylase inhibitor;产品介绍GSK-J1是一种高效的 H3K27 histone demethylase 抑制剂,无细胞试验中对JMJD3 (KDM6B) 和 UTX (KDM6A)的 IC50 分别为 28 nM 和 53 nM,比作用于其他测试的脱甲基酶选择性高10倍多。;Product introductionGSK J1 is a potent and selective inhibitor of the histone H3 lysine 27 (H3K27) demethylase JMJD3, a Fe2+- and α-ketoglutarate-dependent oxygenase involved in a variety of physiological functions including the inflammatory response, with the half maximal inhibition concentration IC50 value of 60 nM .ApplicationGSK-J1 has been used in formaldehyde dehydrogenase (FDH)-coupled demethylase assay.
参考文献:
1. Kruidenier L, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012 Aug 16;488(7411):404-8. 2. Heinemann B, et al. Inhibition of demethylases by GSK-J1/J4. Nature. 2014 Oct 2;514(7520):E1-2 3. Horton JR, et al. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases. J Biol Chem. 2016 Feb 5;291(6):2631-46.